Skip to main content
. 2016 May 23;2016(5):CD007126. doi: 10.1002/14651858.CD007126.pub3

Hynes 2006.

Methods Randomized, double‐blinded, double‐dummy, placebo‐ and active‐controlled
Medication administered on postoperative day 1, when baseline pain reached moderate‐to‐severe intensity
Participants Type of surgery: total hip arthroplasty
Propacetamol group
Entered/completing: 40/40
Age (mean, SD): 65.7 ± 9.8
Sex (male, %): 40
Diclofenac group
Entered/completing: 40/40
Age (mean, SD): 65.6 ± 7.6
Sex (male, %): 55
Placebo group
Entered/completing: 40/40
Age (mean, SD): 66.1 ± 7.1
Sex (male, %): 45
Interventions Intervention: 2 g propacetamol IV
Control: 75 mg diclofenac IM
Placebo: double‐dummy not described
Outcomes Pain intensity (VRS, VAS)
Pain relief (categorical)
Time to request for rescue medication
Global assessment (categorical)
Source of funding Supported by Bristοl‐Myers Squibb
Were treatment groups comparable at baseline? Yes: demographics; duration of anesthesia; baseline postoperative pain
Details of preoperative pain Not reported
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection bias) 
 All outcomes Low risk Double‐dummy technique employed
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk 11/40 missing pain assessment data at 5 h in intervention group due to lack of efficacy and administration of rescue dose (29/40 in placebo group), but all 40 included in efficacy analysis. Data were imputed using LOCF.
Selective reporting (reporting bias) Unclear risk All outcomes from Methods section reported in Results section, but time to rescue was instead reported as number of participants requesting rescue
Size High risk Fewer than 50 participants per arm of the study (40 propacetamol, 40 diclofenac, 40 placebo)